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Background
Lentiviral entry to quiescent lymphocytes represents a
‘time bomb’ waiting for cellular activation to spread
infection. In order to undergo immune activation T cells
interact with dendritic cells presenting peptide:MHC
complexes ‘sampling’ them to look for agonist peptides
and receiving survival signals from self peptides. This
makes the dendritic cell:T cell interaction an ideal
checkpoint to contain lentiviral infection of quiescent
lypmhocytes.
Methods
We have used replication defective lentiviral vectors
expressing reporter genes and/or HIV proteins to study
the innate immune response to lentiviral infection in vitro
using primary mouse and human cells and in vivo in B6
mice. We have used flow cytometry and PCR to quantify
the infection rates in various culture and adoptive transfer
conditions to identify conditions where successful viral
infection is inhibited.
Results
Activating T cells exposed to dendritic cells display
inhibited lentiviral vector infection compared to activated
control cells. This infection reduction is mediated by
dendritic cell:T cell contact. Dendritic cell mediated inhi-
bition of infection reduces over time as cells become fully
activated and proliferate. When using lentiviral vectors
similar results are seen in primary human T cells in cul-
ture. However when replication defective vectors expres-
sing HIV proteins are used to infect T cells de novo
expression of HIV proteins in the host cell prevents DC
mediated inhibition. We have gone on to use knockout
mice to assess the role of established innate immune sen-
sing pathways in DC mediated inhibition but have not
yet identified the molecular sensor mediating this
phenomenon.
Conclusion
The inhibition of productive T cell infection by lentiviral
vectors caused by contact with dendritic cells represents a
previously undescribed innate immune response which we
have called DC mediated inhibition. The successful lenti-
viral pathogen HIV overcomes DC mediated inhibition
enhancing its replication and obscuring this immune
response.
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